Indeed, we and others have shown that in vitro tumor-conditioned tumor-associated macrophages (TAMs) exhibit a mixed M1/M2 macrophage phenotype, expressing both M2 (CD163 and CD206) and M1 (IL-1β, IL-6, TNF-α, and CCL3) markers [18,19]. This evidence concerns the gene MRC1 and neoplasm.